Synopsis of recent research by authors named "Kyoko Nagasue"
Kyoko Nagasue's research primarily focuses on the implications of parathyroid hormone (PTH) and various endocrine markers in patients undergoing hemodialysis and peritoneal dialysis, investigating their roles in renal disease and associated complications.
Significant findings include the effectiveness of cinacalcet in reducing parathyroid gland volume and the potential prognostic value of mesothelial cell area in preventing encapsulating peritoneal sclerosis.
Additionally, studies have explored relationships between biomarkers such as FGF-23 and vitamin D analog responsiveness in managing secondary hyperparathyroidism, highlighting critical cardiovascular risks among end-stage renal disease patients.
